Biogen on aducanumab: ‘We’re ready for an immediate launch’ 09-Jun-2021 By Rachel Arthur Biogen expects to begin shipping Aduhelm (aducanumab-avwa) in two weeks: after the FDA granted the Alzheimer's drug accelerated approval on Monday.
NPD Gallery: Technology Insider 09-Jun-2021 By Jane Byrne What's new in the world of biopharmaceutical tech this month? We track developments in process innovation equipment.
What’s in a name? Quite a lot actually when it comes to substances used in cell and gene therapies 09-Jun-2021 By Jane Byrne The World Health Organization (WHO), as part of its International Nonproprietary Names (INN) system, has recently made progress in developing and harmonizing the definition paragraphs that support the naming of cell-based substances.
